Resource Library

Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these tiers and get started with DCT in 2022 with these pro tips.

Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications. This article explores current regulations for various classes of medical devices and how this will impact the need for participants to visit research sites throughout the trial.

Medical device regulations in the EU have recently undergone a major overhaul. Learn the key tenets of MDR by device classification in this fact sheet, and what checklist items must be addressed to be fully compliant.

Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing the impact of clinical data.

In this whitepaper, we will look at how EDC, eConsent, ePRO, and APIs enable researchers to easily conduct decentralized and hybrid clinical trials.

Castor’s DCT platform helping medical device trials achieve compliance with patient-focused technology  Driving innovation for medical device clinical…

Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization.

A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and maintain public trust.

The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography amongst clinical trial participants. Critically, experts call for not just increased diversity on a statistical basis, but that the studied population is representative of the distribution of the disease.

Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy for their patient enrollment.